ORIGINAL RESEARCH
Published on 09 Apr 2024
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
doi 10.3389/fphar.2024.1251961
- 3,206 views
- 1 citation
- Frontiers in Pharmacology
- Pharmacoepidemiology
- Research Topics
- Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety
Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety
13k
Total downloads
51k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 27 Mar 2024
Detection of iodixanol-induced allergic reaction signals in Chinese inpatients: a multi-center retrospective database study using prescription sequence symmetry analysis
doi 10.3389/fphar.2024.1298021
- 749 views
ORIGINAL RESEARCH
Published on 31 Jan 2024
Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
doi 10.3389/fphar.2024.1280201
- 2,220 views
- 5 citations
ORIGINAL RESEARCH
Published on 21 Dec 2023
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
doi 10.3389/fphar.2023.1259611
- 4,247 views
- 12 citations
ORIGINAL RESEARCH
Published on 19 Dec 2023
Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
doi 10.3389/fphar.2023.1301120
- 3,173 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 Nov 2023
Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study
doi 10.3389/fphar.2023.1275095
- 1,342 views
- 2 citations
ORIGINAL RESEARCH
Published on 16 Nov 2023
Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
doi 10.3389/fphar.2023.1284287
- 1,671 views
- 4 citations
ORIGINAL RESEARCH
Published on 30 Oct 2023
Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study
doi 10.3389/fphar.2023.1165711
- 3,321 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 Oct 2023
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
doi 10.3389/fphar.2023.1259908
- 3,628 views
- 13 citations
ORIGINAL RESEARCH
Published on 02 Oct 2023
Infections associated with clozapine: a pharmacovigilance study using VigiBase®
doi 10.3389/fphar.2023.1260915
- 2,774 views
- 2 citations
ORIGINAL RESEARCH
Published on 12 Jul 2023
Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
doi 10.3389/fphar.2023.1182113
- 3,756 views
- 8 citations
ORIGINAL RESEARCH
Published on 11 Jul 2023
Active surveillance and clinical analysis of anaphylaxis based on the China Hospital Pharmacovigilance System
doi 10.3389/fphar.2023.1180685
- 1,650 views
- 3 citations
